Core Concepts in Pharmacoepidemiology: Time-To-Event Analysis Approaches in Pharmacoepidemiology

被引:0
作者
Rippin, Gerd [1 ]
Salmasi, Shahrzad [2 ]
Sanz, Hector [3 ]
Largent, Joan [4 ]
机构
[1] IQVIA Commercial GmbH & Co OHG, Stat Serv, Frankfurt, Germany
[2] IQVIA Canada, Epidemiol, Kirkland, PQ, Canada
[3] IQVIA Espana Barcelona, Stat Serv, Barcelona, Spain
[4] IQVIA Deerfield, Epidemiol, Deerfield, IL USA
关键词
causal inference; survival analysis; time-to-event analysis; SURVIVAL; HAZARDS;
D O I
10.1002/pds.5886
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
AimThis article provides an overview of time-to-event (TTE) analysis in pharmacoepidemiology.Materials & MethodsThe key concept of censoring is reviewed, including right-, left-, interval- and informative censoring. Simple descriptive statistics are explained, including the nonparametric estimation of the TTE distribution as per Kaplan-Meier method, as well as more complex TTE regression approaches, including the parametric Accelerated Failure Time (AFT) model and the semi-parametric Cox Proportional Hazards and Restricted Mean Survival Time (RMST) models. Additional approaches and various TTE model extensions are presented as well. Finally, causal inference for TTE outcomes is addressed.ResultsA thorough review of the available concepts and methods outlines the immense variety of available and useful TTE models.DiscussionThere may be underused TTE concepts and methods, which are highlighted to raise awareness for researchers who aim to apply the most appropriate TTE approach for their study.ConclusionThis paper constitutes a modern summary of TTE analysis concepts and methods. A curated list of references is provided.
引用
收藏
页数:12
相关论文
共 68 条
  • [41] Lio Y., 2022, Bayesian Inference and Computation in Reliability and Survival Analysis (Emerging Topics in Statistics and Biostatistics), DOI [10.1007/978-3-030-88658-5, DOI 10.1007/978-3-030-88658-5]
  • [42] Manzoor B S., 2017, Value Outcomes Spotlight, V3, P21
  • [43] On the propensity score weighting analysis with survival outcome: Estimands, estimation, and inference
    Mao, Huzhang
    Li, Liang
    Yang, Wei
    Shen, Yu
    [J]. STATISTICS IN MEDICINE, 2018, 37 (26) : 3745 - 3763
  • [44] Subtleties in the interpretation of hazard contrasts
    Martinussen, Torben
    Vansteelandt, Stijn
    Andersen, Per Kragh
    [J]. LIFETIME DATA ANALYSIS, 2020, 26 (04) : 833 - 855
  • [45] Moore D, 2016, Applied Survival Analysis Using R, V1st, DOI DOI 10.1007/978-3-319-31245-3
  • [46] Peace K. E., 2018, Design and Analysis of Clinical Trials With TimeToEvent Endpoints, DOI [10.1201/9781420066401, DOI 10.1201/9781420066401]
  • [47] Prentice RL., 2019, STAT ANAL MULTIVARIA
  • [48] Rizopoulos D, 2012, CH CRC BIOSTAT SER, P1, DOI 10.1201/b12208
  • [49] Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
    Royston, P
    Parmar, MKB
    [J]. STATISTICS IN MEDICINE, 2002, 21 (15) : 2175 - 2197
  • [50] Royston P., 2011, Flexible parametric survival analysis using stata: Beyond the Cox model